iQIYI (IQ) Senior VP adjusts expiring stock option grants

Rhea-AI Filing Summary

iQIYI, Inc. Senior Vice President Yang Xianghua reported option amendments and grants, not open-market share trades. The filing shows two derivative transactions granting options over 5,600,000 and 4,812,117 Class A ordinary shares at an exercise price of 0.5119, paired with corresponding dispositions of options for the same amounts back to the issuer.

Footnotes explain these as amendments of fully vested outstanding options that extended their expiration dates from 2027 and 2028 to 2030, which may be deemed cancellations and new grants. Additional options over 2,450,000 shares at a 0.0000 exercise price and 2,275,000 shares at a 0.5119 exercise price remain outstanding and expire in 2036, with vesting beginning on 05/11/2026 under four-year schedules.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Yang Xianghua

Role Senior Vice President

Type	Security	Shares	Price	Value
Disposition	Option (right to buy)	4,812,117	$0.00	--
Grant/Award	Option (right to buy)	4,812,117	$0.00	--
Disposition	Option (right to buy)	5,600,000	$0.00	--
Grant/Award	Option (right to buy)	5,600,000	$0.00	--
holding	Option (right to buy)	--	--	--
holding	Option (right to buy)	--	--	--

Holdings After Transaction: Option (right to buy) — 0 shares (Direct, null)

Footnotes (1)

1. The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

Key Figures

Option grant size 1: 5,600,000 underlying shares Option grant size 2: 4,812,117 underlying shares Remaining options (0.0000): 2,450,000 underlying shares +3 more

6 metrics

Option grant size 1 5,600,000 underlying shares Options at 0.5119 exercise price, expiring 10/18/2030

Option grant size 2 4,812,117 underlying shares Options at 0.5119 exercise price, expiring 10/18/2030

Remaining options (0.0000) 2,450,000 underlying shares Exercise price 0.0000, expiration 05/11/2036, direct holding

Remaining options (0.5119) 2,275,000 underlying shares Exercise price 0.5119, expiration 05/11/2036, direct holding

Vesting schedule F1 25% then 75% in 12 quarters Options vest from 1st anniversary of 05/11/2026

Vesting schedule F2 25% each year over 4 years Options vest on 1st–4th anniversaries of 05/11/2026

Key Terms

Option (right to buy, Grant, award, or other acquisition, Disposition to issuer, vest over a four-year period, +1 more

5 terms

Option (right to buy financial

"security_title": "Option (right to buy)"

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Disposition to issuer financial

"transaction_code_description": "Disposition to issuer""

vest over a four-year period financial

"The options vest over a four-year period, with 25% vesting"

expiration date financial

"The two reported transactions involved an amendment of outstanding options to extend the expiration date"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yang Xianghua

(Last) (First) (Middle)

4F, IQIYI YOUTH CENTER, YOOLEE PLAZA

NO.21 NORTH ROAD OF WORKERS' STADIUM

(Street)

BEIJING CHINA 100027

(City) (State) (Zip)

CHINA

(Country)

2. Issuer Name and Ticker or Trading Symbol
iQIYI, Inc. [ IQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$0.5119							(1)	05/11/2036	Class A ordinary share	2,275,000		2,275,000	D
Option (right to buy)	$0							(2)	05/11/2036	Class A ordinary share	2,450,000		2,450,000	D
Option (right to buy)	$0.5119	05/11/2026		D			4,812,117	(3)	02/14/2027	Class A ordinary share	4,812,117	(4)	0	D
Option (right to buy)	$0.5119	05/11/2026		A		4,812,117		(3)	10/18/2030	Class A ordinary share	4,812,117	(4)	4,812,117	D
Option (right to buy)	$0.5119	05/11/2026		D			5,600,000	(5)	02/28/2028	Class A ordinary share	5,600,000	(6)	0	D
Option (right to buy)	$0.5119	05/11/2026		A		5,600,000		(5)	10/18/2030	Class A ordinary share	5,600,000	(6)	5,600,000	D

Explanation of Responses:

1. The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

2. The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.

3. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

4. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.

5. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

6. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

	/s/ Yang Xianghua	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did iQIYI (IQ) executive Yang Xianghua report in this Form 4?

Yang Xianghua reported amendments and grants of stock options, not open-market trades. The transactions involve cancelling fully vested options and granting new options over identical share amounts with extended expiration dates and specified four-year vesting schedules tied to anniversaries of 02/14/2017, 02/28/2018, and 05/11/2026.

How many iQIYI options were amended or re-granted in Yang Xianghua’s filing?

The filing shows option transactions covering 5,600,000 and 4,812,117 underlying Class A ordinary shares. Each grant is paired with a disposition of options over the same share amount to the issuer, reflecting amendments that extend the options’ expiration dates rather than new open-market acquisitions or sales.

What are the exercise prices on Yang Xianghua’s iQIYI stock options?

The reported options include grants at an exercise price of 0.5119 per underlying Class A ordinary share and existing positions at both 0.0000 and 0.5119. These prices apply to options that vest over four years and expire on specified dates in 2030 and 2036, according to the filing.

When do Yang Xianghua’s amended iQIYI options expire and how do they vest?

The amended options now expire on 10/18/2030, extended from earlier 2027 and 2028 dates. Footnotes state vesting occurs over four years, with 25% vesting on the first or each anniversary of 05/11/2026, and remaining portions vesting in 12 equal quarterly installments thereafter, as applicable.

What option holdings remain for Yang Xianghua after these iQIYI transactions?

The derivative holdings summary shows remaining options over 2,450,000 underlying Class A ordinary shares at a 0.0000 exercise price and 2,275,000 underlying shares at a 0.5119 exercise price. Both sets of options are held directly and are scheduled to expire on 05/11/2036 under the reported terms.